Outcomes of Resectability Assessment of the Dutch Colorectal Cancer Group Liver Metastases Expert Panel

Autor: Huiskens, J., Bolhuis, K., Engelbrecht, M.R.W., Jong, K.P. de, Kazemier, G., Liem, M.S.L., Verhoef, C., Wilt, J.H.W. de, Punt, C.J.A., Gulik, T.M. van, Amerongen, M.J. van, Dejong, C.H.C., Gerhards, M.F., Grunhagen, D., Heijmen, L., Hermans, J.J., Keijser, A., Klaase, J.M., Lienden, K.P. van, Molenaar, Q.I., Patijn, G.A., Rijken, A.M., Ruers, T.M., Swijnenbur, R.J., Tinteren, H. van, Dutch Colorectal Canc Grp

Publikováno v: Journal of the American College of Surgeons, 229(6), 523-532. Elsevier Inc.
Journal of The American College of Surgeons, 229(6), 523
Journal of the American College of Surgeons, 229(6), 523-532.e2. Elsevier Inc.
Journal of the American College of Surgeons, 229, 6, pp. 523
Journal of the American College of Surgeons, 229(6), 523-532.e2. Elsevier Science
Journal of the American College of Surgeons, 229, 523
Journal of the american college of surgeons, 229(6), 523-532.e2. ELSEVIER SCIENCE INC

BACKGROUND: Decision making on optimal treatment strategy in patients with initially unresectable colorectal cancer liver metastases (CRLM) remains complex because uniform criteria for (un) resectability are lacking. This study reports on the feasibi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ca01e90cd8794e41a294e3bd483faa2
https://hdl.handle.net/1887/121486